FINAZZI, MARIA CHIARA

FINAZZI, MARIA CHIARA  

Dipartimento di Oncologia ed Emato-Oncologia  

Mostra records
Risultati 1 - 20 di 31 (tempo di esecuzione: 0.0 secondi).
Titolo Data di pubblicazione Autori Tipo File Abstract
Ropeginterferon phase 2 randomized study in low-risk polycythemia vera: 5-year drug survival and efficacy outcomes 2024 Cattaneo, DanieleFinazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -
Allogeneic hematopoietic cell transplantation in patients with CALR-mutated myelofibrosis: a study of the Chronic Malignancies Working Party of EBMT 2023 Finazzi, Maria Chiara + Article (author) -
Clonal Hematopoiesis in Myeloproliferative Neoplasms Confers a Predisposition to both Thrombosis and Cancer 2023 Finazzi, Maria Chiara + Article (author) -
Ropeginterferon versus Standard Therapy for Low-Risk Patients with Polycythemia Vera 2023 Carioli, GretaRicco, AlessandraCaramella, MariannaPatriarca, AndreaMora, BarbaraBucelli, CristinaFinazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -
Outcomes after allogeneic hematopoietic cell transplant in patients diagnosed with blast phase of myeloproliferative neoplasms: A retrospective study from the Chronic Malignancies Working Party of the European Society for Blood and Marrow Transplantation 2023 Finazzi, Maria Chiara + Article (author) -
Impact of ruxolitinib on survival of patients with myelofibrosis in the real world: Update of the ERNEST Study 2022 Finazzi M. C.Rambaldi A.Passamonti F. + Article (author) -
A prognostic model to predict survival after 6 months of ruxolitinib in patients with myelofibrosis 2022 Finazzi, Maria ChiaraGuidetti, AnnaCattaneo, DanielePassamonti, Francesco + Article (author) -
Increased risk of thrombosis in JAK2 V617F-positive patients with primary myelofibrosis and interaction of the mutation with the IPSS score 2022 Carioli, GretaRambaldi, AlessandroFinazzi, Maria ChiaraPassamonti, Francesco + Article (author) -
Pre-existing immune checkpoints activation predicts relapse after allogeneic stem cell transplantation in lymphoma 2021 Derenzini, EnricoFinazzi, Maria ChiaraRambaldi, AlessandroTarella, Corrado + Article (author) -
Ropeginterferon alfa-2b versus phlebotomy in low-risk patients with polycythaemia vera (Low-PV study): a multicentre, randomised phase 2 trial 2021 Caramella, MariannaPatriarca, AndreaBucelli, CristinaFinazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -
Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis 2020 Finazzi M. C. + Article (author) -
Characteristics of graft-versus-host disease occurring after alemtuzumab-containing allogeneic stem cell transplants: incidence, organ involvement, risk factors and survival 2020 Finazzi M. C.Rambaldi A. + Article (author) -
A multistate model of survival prediction and event monitoring in prefibrotic myelofibrosis 2020 Rambaldi A.Finazzi M. C. + Article (author) -
A prospective evaluation of pegylated interferon alfa-2a therapy in patients with polycythemia vera and essential thrombocythemia with a prior splanchnic vein thrombosis 2019 Finazzi, M CRambaldi, A + Article (author) -
Second primary malignancies in ruxolitinib-treated myelofibrosis : real-world evidence from 219 consecutive patients 2019 Finazzi M. C.Caramella M.Cattaneo D.Accetta R.Passamonti F. + Article (author) -
Busulfan or thiotepa based conditioning in myelofibrosis: A phase II multicenter randomized study from the GITMO group 2019 Finazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -
Pegylated interferon alfa-2a for polycythemia vera or essential thrombocythemia resistant or intolerant to hydroxyurea 2019 Finazzi M. C.Rambaldi A. + Article (author) -
Blast phase myeloproliferative neoplasm: Mayo-AGIMM study of 410 patients from two separate cohorts 2018 Passamonti, FrancescoFinazzi, Maria ChiaraRambaldi, Alessandro + Article (author) -
Benefit-risk profile of cytoreductive drugs along with antiplatelet and antithrombotic therapy after transient ischemic attack or ischemic stroke in myeloproliferative neoplasms 2018 Finazzi M. C.Cattaneo D.Cortelezzi A. + Article (author) -
A reappraisal of the benefit-risk profile of hydroxyurea in polycythemia vera : a propensity-matched study 2017 Finazzi M. C. + Article (author) -